eli-lilly-and-company

Documents about eli-lilly-and-company

• W58P0522C0012 — ELI LILLY AND COMPANY — Department of Defense ($1,463,250,000)#604821USAspending
• W911QY21C0016 — ELI LILLY AND COMPANY — Department of Defense ($1,373,930,000)#604860USAspending
• W58P0522F0001 — ELI LILLY AND COMPANY — Department of Defense ($1,289,400,000)#604930USAspending
• Major Depressive Disorder (MDD)#831594ClinicalTrials.gov
• EVA: Evista Alendronate Comparison#1340462ClinicalTrials.gov
• LY2189265 and Atorvastatin Interaction Study#1114289ClinicalTrials.gov
• A Study of LY900020 in Healthy Chinese Participants#405117ClinicalTrials.gov
• A Study in People With Mild Hypertension#405233ClinicalTrials.gov
• Tadalafil in Subjects With Mild to Moderate Hypertension#674804ClinicalTrials.gov
• A Study for Patients With Osteoporosis#838910ClinicalTrials.gov
• A Device Study in Healthy Participants#1045016ClinicalTrials.gov
• A Study in Recurrent Glioblastoma (GB)#1163382ClinicalTrials.gov
• Study of LY3154207 in Healthy Participants#1379176ClinicalTrials.gov
• A Study in Rheumatoid Arthritis#1420354ClinicalTrials.gov
• Teriparatide Use in Hip Replaced Subjects#1420616ClinicalTrials.gov
• Efficacy and Safety of Duloxetine#878012ClinicalTrials.gov
• Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma#1046400ClinicalTrials.gov
• A Study of LY3526318 in Healthy Male Japanese Participants#152356ClinicalTrials.gov
• A Study of LY4355756 in Healthy Participants#831030ClinicalTrials.gov
• A Study of Ixekizumab in Healthy Participants#842480ClinicalTrials.gov
• A Study of LY3985863 in Healthy Participants#843526ClinicalTrials.gov
• A Study of LY3041658 in Healthy Participants#854335ClinicalTrials.gov
• A Study of LY3537031 in Healthy Participants#869109ClinicalTrials.gov
• A Study of Abemaciclib in Healthy Participants#883842ClinicalTrials.gov
• A Study of LY3857210 in Healthy Participants#885891ClinicalTrials.gov
• A Study of LY3532226 in Healthy Participants#904852ClinicalTrials.gov
• A Study of LY3461767 in Healthy Participants#905932ClinicalTrials.gov
• A Study of LY3463251 in Healthy Participants#906560ClinicalTrials.gov
• A Study of LY3867070 in Healthy Participants#910615ClinicalTrials.gov
• A Study of LY3451838 in Healthy Participants#912795ClinicalTrials.gov
• Fibromyalgia Health Outcome Study on Cost of Treatments#916636ClinicalTrials.gov
• A Study of LY3305677 in Healthy Participants#918606ClinicalTrials.gov
• A Study of LY3323795 in Healthy Participants#980820ClinicalTrials.gov
• A Study of LY4226695 in Healthy Participants#993173ClinicalTrials.gov
• A Study of Mirikizumab in Healthy Participants#1009614ClinicalTrials.gov
• A Study of Baricitinib in Healthy Participants#1033248ClinicalTrials.gov
• A Study of Galcanezumab in Healthy Participants.#1033648ClinicalTrials.gov
• A Study of LY4302814 in Healthy Participants#1058487ClinicalTrials.gov
• A Study of LY3556050 in Healthy Participants#1071983ClinicalTrials.gov
• A Study of LY3819469 in Healthy Participants#1101501ClinicalTrials.gov
• A Study of LY3502970 in Healthy Participants#1138336ClinicalTrials.gov
• A Study of LY3154885 in Healthy Participants#1140984ClinicalTrials.gov
• Combination Chemotherapy for Metastatic Breast Cancer#1172591ClinicalTrials.gov
• A Study of LY3493269 in Healthy Participants#1183559ClinicalTrials.gov
• The Cymbalta Pregnancy Registry#1195366ClinicalTrials.gov
• Combination Therapy in Patients With Depression#1212748ClinicalTrials.gov
• A Study of LY3475766 in Healthy Participants#1214570ClinicalTrials.gov
• A Study of Lasmiditan in Healthy Participants#1244821ClinicalTrials.gov
• A Study of LY4088044 in Healthy Participants#1306880ClinicalTrials.gov
• A Study of LY3522348 in Healthy Participants#1336763ClinicalTrials.gov